[The diagnostic value of pharmacoangiography in tumourous and inflammatory diseases of bones and soft tissues (author's transl)]. 1980

G Lechner, and G Powischer, and R Waneck

The value of pharmaco-angiography (Priscol, angiotensin) in the diagnosis of tumourous and inflammatory diseases in bones and soft tissues was investigated in 81 patients. Priscol was used in 49 patients, angiotensin in 28 and both substances in four. It was shown that neither Priscol nor angiotensin produced results of diagnostic value, provided an optimal technique was used (antegrade, selective contrast injection with an adequate volume of contrast and in the absence of vascular spasm). Priscol was of value for reducing or preventing spasm in peripheral vessels. Angiotensin is superior to Priscol in demonstrating the angiographic criteria, but pharmaco-angiography did not result in a better distinction between tumours and inflammatory lesions.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010000 Osteitis Inflammation of the bone. Bone Inflammation,Inflammation, Bone
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000792 Angiography Radiography of blood vessels after injection of a contrast medium. Arteriography,Angiogram,Angiograms,Angiographies,Arteriographies
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

G Lechner, and G Powischer, and R Waneck
March 1974, Deutsche medizinische Wochenschrift (1946),
G Lechner, and G Powischer, and R Waneck
January 1980, Wiener klinische Wochenschrift,
G Lechner, and G Powischer, and R Waneck
January 1980, Journal de gynecologie, obstetrique et biologie de la reproduction,
G Lechner, and G Powischer, and R Waneck
December 1976, Der Radiologe,
G Lechner, and G Powischer, and R Waneck
August 1974, Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca,
G Lechner, and G Powischer, and R Waneck
January 1980, Polski przeglad radiologii i medycyny nuklearnej,
G Lechner, and G Powischer, and R Waneck
October 1979, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
G Lechner, and G Powischer, and R Waneck
December 1981, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
G Lechner, and G Powischer, and R Waneck
March 1982, Journal de radiologie,
G Lechner, and G Powischer, and R Waneck
October 1975, No shinkei geka. Neurological surgery,
Copied contents to your clipboard!